Spots Global Cancer Trial Database for pancreatic adenocarcinoma metastatic
Every month we try and update this database with for pancreatic adenocarcinoma metastatic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PD-1 Antibody and Sapropterin Dihydrochloride in Patients With PDAC | NCT06396637 | Pancreatic Aden... | Sapropterin Dih... | 18 Years - 75 Years | Sun Yat-sen University | |
| To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers | NCT02179970 | Pancreatic Aden... Ovarian Serous ... Colorectal Canc... | Plerixafor | 16 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| QUILT-2.022 NANT-008 in Combination w/ 5-fluorouracil, Bevacizumab, Leucovorin & Oxaliplatin in Subjects With Pancreatic Cancer | NCT03127124 | Pancreatic Aden... | NANT-008 Fluorouracil In... Avastin Injecta... Leucovorin Calc... Eloxatin Inject... | 18 Years - 65 Years | NantPharma, LLC | |
| Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer | NCT01715142 | Pancreatic Aden... Pancreatic Aden... Pancreatic Aden... | Gemcitabine Abraxane | 18 Years - | Erasme University Hospital | |
| Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma | NCT02195180 | Pancreatic Aden... | ERY001 Gemcitabine 5-fluoro-uracil... | 18 Years - | ERYtech Pharma | |
| To Assess the Safety of Continuous IV Administration of Plerixafor in Patients With Advanced Pancreatic, Ovarian and Colorectal Cancers | NCT02179970 | Pancreatic Aden... Ovarian Serous ... Colorectal Canc... | Plerixafor | 16 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Real World Efficacy, Safety of Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Metastatic Pancreatic Cancer After Previous Gemcitabine-based Therapy | NCT06006728 | Pancreatic Aden... | 18 Years - | University Hospital, Bordeaux | ||
| Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma | NCT02195180 | Pancreatic Aden... | ERY001 Gemcitabine 5-fluoro-uracil... | 18 Years - | ERYtech Pharma | |
| Scheduling Nab-paclitaxel With Gemcitabine | NCT03529175 | Pancreatic Aden... | Abraxane (nab-p... Gemcitabine | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer | NCT06051851 | Pancreatic Aden... | Penpulimab Anlotinib Nab paclitaxel Gemcitabine | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Real World Efficacy, Safety of Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in Metastatic Pancreatic Cancer After Previous Gemcitabine-based Therapy | NCT06006728 | Pancreatic Aden... | 18 Years - | University Hospital, Bordeaux | ||
| FOLFIRINOX + 9-Ing-41 + Losartan In Pancreatic Cancer | NCT05077800 | Pancreatic Aden... Pancreatic Aden... | FOLFIRNINOX Losartan 9-ING-41 | 18 Years - | Massachusetts General Hospital | |
| Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma | NCT03633734 | Pancreatic Aden... Chemotherapy Ef... | Sequential Trea... | 18 Years - 80 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Effect on Tumor Perfusion of a Chemotherapy Combining Gemcitabine and Nab-paclitaxel (Abraxane) in Pancreatic Cancer | NCT01715142 | Pancreatic Aden... Pancreatic Aden... Pancreatic Aden... | Gemcitabine Abraxane | 18 Years - | Erasme University Hospital | |
| Scheduling Nab-paclitaxel With Gemcitabine | NCT03529175 | Pancreatic Aden... | Abraxane (nab-p... Gemcitabine | 18 Years - | Cambridge University Hospitals NHS Foundation Trust | |
| The Seven Trial: Exploiting the Unfolded Protein Response | NCT06076837 | Pancreatic Canc... Pancreatic Aden... | Botensilimab Balstilimab Chloroquine Pho... Celecoxib | 18 Years - | HonorHealth Research Institute | |
| tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr | NCT05360264 | Pancreatic Aden... Pancreatic Aden... | Decitabine 50 M... | 18 Years - | Regina Elena Cancer Institute | |
| Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer | NCT01053013 | Pancreatic Aden... Pancreatic Aden... Colorectal Canc... | RENCA macrobead... | 18 Years - | The Rogosin Institute | |
| The Seven Trial: Exploiting the Unfolded Protein Response | NCT06076837 | Pancreatic Canc... Pancreatic Aden... | Botensilimab Balstilimab Chloroquine Pho... Celecoxib | 18 Years - | HonorHealth Research Institute | |
| Cabozantinib and Erlotinib for Patients With EGFR and c-Met Co-expressing Metastatic Pancreatic Adenocarcinoma | NCT03213626 | Pancreatic Aden... | Cabozantinib 40... Erlotinib 100Mg... | 18 Years - | Indiana University | |
| Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic/Colorectal Cancer | NCT01053013 | Pancreatic Aden... Pancreatic Aden... Colorectal Canc... | RENCA macrobead... | 18 Years - | The Rogosin Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
